Does Dr. DIALA EL-MAOUCHE have financial conflicts of interest?

Dr. DIALA EL-MAOUCHE (MD, MS) has received a total of $100,063 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $99,147 in personal promotional payouts (consulting, meals, travel) and $916 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DIALA EL-MAOUCHE?

According to CMS Open Payments data, Dr. DIALA EL-MAOUCHE received funding from ALEXION PHARMACEUTICALS ($82,846), SANOFI-AVENTIS U.S ($14,828), and NEUROCRINE BIOSCIENCES ($916).

Does Dr. DIALA EL-MAOUCHE receive research grants or speaking fees?

Dr. DIALA EL-MAOUCHE has received $99,147 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $916 in clinical research grants.

DR. DIALA EL-MAOUCHE

MD, MSReal-Time Hydrated

Specialty: Internal Medicine, Endocrinology, Diabetes & Metabolism

Practice Location: WASHINGTON, DC 20037

NPI Number: 1487817821

LIFETIME INDUSTRY VALUE

$100,063

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. EL-MAOUCHE is a verified Internal Medicine, Endocrinology, Diabetes & Metabolism practitioner based in WASHINGTON, DC.

Between 2021 and 2025, Dr. EL-MAOUCHE had an overall industry promotional and research financial footprint of $100,063 as recorded in the federal CMS Open Payments database.

$99,147 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$916 was allocated to sponsored clinical trials and medical research activities.

Dr. EL-MAOUCHE's primary funding source is ALEXION PHARMACEUTICALS, which accounts for $82,846 (representing 82.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ALEXION PHARMACEUTICALS

Rank 1

$82,846

82.8%

SANOFI-AVENTIS U.S

Rank 2

$14,828

14.8%

NEUROCRINE BIOSCIENCES

Rank 3

$916

0.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.